Depletion of the diabetic gut microbiota resistance enhances stem cells therapy in type 1 diabetes mellitus

Microbiome, considered as the “second genome” of the host, is altered in type 1 diabetes mellitus (T1DM) patients to a state of dysbiosis. Mesenchymal stem cell (MSC) transplantation is a promising treatment for T1DM but is limited by several factors in the diabetic host. In this study, we tested th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Wanqi, Graves, Dana T., He, Linhai, Shi, Yan, Deng, Xuliang, Zhao, Yajun, Dong, Xian, Ren, Yi, Liu, Xinhua, Xiao, E, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255019/
https://www.ncbi.nlm.nih.gov/pubmed/32483466
http://dx.doi.org/10.7150/thno.44113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255019/
https://www.ncbi.nlm.nih.gov/pubmed/32483466
http://dx.doi.org/10.7150/thno.44113

Ejemplares similares